| 000 | 01869 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516055709.0 | ||
| 264 | 0 | _c20120913 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1529-0131 | ||
| 024 | 7 |
_a10.1002/art.33342 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRuperto, Nicolino | |
| 245 | 0 | 0 |
_aA phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cFeb 2012 |
||
| 300 |
_a557-67 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Juvenile _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-1beta _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aQuartier, Pierre | |
| 700 | 1 | _aWulffraat, Nico | |
| 700 | 1 | _aWoo, Patricia | |
| 700 | 1 | _aRavelli, Angelo | |
| 700 | 1 | _aMouy, Richard | |
| 700 | 1 | _aBader-Meunier, Brigitte | |
| 700 | 1 | _aVastert, Sebastiaan J | |
| 700 | 1 | _aNoseda, Emanuele | |
| 700 | 1 | _aD'Ambrosio, Daniele | |
| 700 | 1 | _aLecot, Jean | |
| 700 | 1 | _aChakraborty, Abhijit | |
| 700 | 1 | _aMartini, Alberto | |
| 700 | 1 | _aChioato, Andrea | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 64 _gno. 2 _gp. 557-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.33342 _zAvailable from publisher's website |
| 999 |
_c21190567 _d21190567 |
||